Retrieved from Eli Lilly and Company-a
Both GLP-1s and GIPs are tied to plenty of other compelling health benefits outside of weight loss, including diabetes management, reduced heart disease risk, and, potentially, dementia prevention
Acknowledgements Graphical Abstract, Figure 1, and Figure 2 were created using Biorender
For brain fog and cognitive symptoms Brain fog on GLP-1 medications is often linked to a combination of dehydration, low sodium, and low magnesium
Eli Lilly delivered a Q1 2026 trifectaearnings beat, raised full-year guidance, and early-April FDA approval of Foundayo, the first oral GLP-1 with no food or water restrictionswidening its lead over Novo Nordisk just as the race for a convenient weight-loss pill heats up
GLP-1 only treatments and oral options still deliver strong results but typically show slightly lower average weight loss because they target a single receptor pathway